Edwards Lifesciences Corp banner

Edwards Lifesciences Corp
BMV:EW

Watchlist Manager
Edwards Lifesciences Corp Logo
Edwards Lifesciences Corp
BMV:EW
Watchlist
Price: 2 127.8601 MXN 0.6% Market Closed
Market Cap: Mex$41.9B

Wall St Price Targets

EW Price Targets Summary
Edwards Lifesciences Corp

Wall Street analysts forecast EW stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for EW is 1 845.6173 MXN with a low forecast of 1 538.0144 MXN and a high forecast of 2 069.1981 MXN.

Lowest Forecast
Price Target
1 538.0144 MXN
28% Downside
Average Forecast
Price Target
1 845.6173 MXN
13% Downside
Highest Forecast
Price Target
2 069.1981 MXN
3% Downside
Edwards Lifesciences Corp Competitors:
Price Targets

Revenue
Forecast

9% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
9% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 5 years is 10%.

Gross Profit
Forecast

10% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
10% / Year
Past Growth
10% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 5 years is 10%.

Operating Income
Forecast

11% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
11% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 5 years is 13%.

Pre-Tax Income
Forecast

10% / Year
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss
10% / Year
Past Growth
28% / Year
Estimated Growth
Estimates Accuracy
-11%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 28%.

Net Income
Forecast

11% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
11% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 5 years is 20%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is EW's stock price target?
Price Target
1 845.6173 MXN

According to Wall Street analysts, the average 1-year price target for EW is 1 845.6173 MXN with a low forecast of 1 538.0144 MXN and a high forecast of 2 069.1981 MXN.

What is the Revenue forecast for Edwards Lifesciences Corp?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 5 years is 10%.

What is the Gross Profit forecast for Edwards Lifesciences Corp?
Projected CAGR
10%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 10%. The projected CAGR for the next 5 years is 10%.

What is the Operating Income forecast for Edwards Lifesciences Corp?
Projected CAGR
13%

Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 5 years is 13%.

What is the Pre-Tax Income forecast for Edwards Lifesciences Corp?
Projected CAGR
28%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 10%. The projected CAGR for the next 3 years is 28%.

What is the Net Income forecast for Edwards Lifesciences Corp?
Projected CAGR
20%

Over the last 13 years, the compound annual growth rate for Net Income has been 11%. The projected CAGR for the next 5 years is 20%.

Back to Top